Slingshot members are tracking this event:

CHMP Recommends Approval of Bristol-Myers Squibb's (BMY) Opdivo as Single Agent for Squamous Cell Cancer of the Head and Neck After Platinum-Based Chemotherapy

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 24, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Chmp, Opdivo, Squamous Cell Cancer, Head And Neck Cancer, Platinum-based Chemotherapy, European Medicines Agency